NICE recommendation for Tafinlar® (dabrafenib) for the treatment of metastatic melanoma patients in England and Wales

GlaxoSmithKline (GSK) has announced that the National Institute for Health and Care Excellence (NICE) issued its final appraisal determination (FAD) recommending the use of Tafinlar®...